Yahoo News |
Mylan sets sights on production of generic asthma inhaler
Tribune-Review Besides providing a cheaper alternative for asthma sufferers across the country, being first to market with generic Advair is seen as key to Mylan's drive to boost growth and hit an ambitious earnings target of adjusted net income of at least $6 a … Mylan: Advair Generic Ready For Launch |
View full post on asthma – Google News